Surviving the loneliness epidemic: development of an intervention to reduce social isolation and loneliness among persons with multiple sclerosis (MS) kessler foundation, in partnership with the…

Active Grant Awarded

Award ID
90IFDV0051
Recipient
Awarding agency
Obligated
$249,426

Award facts

Completion date 5% complete
Place of performance
East Hanover, NJ, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services Administration for Community Living awarded Kessler Foundation, Inc. a grant totaling $249,426 on September 23, 2026, under the ACL National Institute on Disability, Independent Living, and Rehabilitation Research program (CFDA 93.433). The award carries the alternate agency name National Institute on Disability Independent Living and Rehabilitation Research. The three-year project runs through September 29, 2029, with work performed in East Hanover, New Jersey.

The grant funds further development of the Community Re-Integration for Socially Isolated Patients (CRISP) intervention, which is designed to reduce social isolation and loneliness among persons with multiple sclerosis. Kessler is partnering with the developer of CRISP. The project moves a working prototype that has met critical technical requirements toward testing in natural or less controlled contexts, with iterative refinement based on stakeholder input.

Phase one consists of focus groups with stakeholders, including people with MS who are most at risk for loneliness and MS peer group leaders who would ultimately deliver the intervention. Phase two uses those findings to develop an intervention manual and participant workbook. Phase three centers on training facilitators.

The program supports research and its utilization to improve the lives of people with physical and mental disabilities, with an emphasis on persons with severe disabilities.

Description

Surviving the loneliness epidemic: development of an intervention to reduce social isolation and loneliness among persons with multiple sclerosis (MS) kessler foundation, in partnership with the developer of the community RE-integration for socially isolated patients (CRISP) intervention will, over the course of this three-year project, refine and manualize an existing, empirically supported intervention, which had been adopted into clinical practice in a MS clinic for over a decade and proven effective in increasing self-efficacy and reducing loneliness among individuals with multiple sclerosis (MS). However, further development of the CRISP intervention is needed to ensure that IT is appropriate for those most at risk for loneliness and feasible in other contexts and settings. Thus, the goal of the proposed project is to further the development of the intervention, which falls within the proof of product developmental stage as IT consists of taking a working prototype/intervention that has met critical technical requirements and iteratively refining the prototype/intervention following input from stakeholders and testing the intervention in natural or less controlled contexts and verifying that all technical requirements can be met. Various objectives and outcomes are anticipated over the three phases of the project. The first phase of the study involves refining the intervention and will consist of conducting focus groups with stakeholders including those with MS who are most at risk for loneliness and MS peer group leaders who would ultimately be conducting the intervention. In phase two, findings from the focus groups will guide the development of an intervention manual and participant workbook. The third and final phase of further developing the CRISP intervention will involve the training of facilitators and moving the intervention out of the controlled setting in which IT was developed. A randomized controlled trial (RCT) will then be conducted to determine the feasibility (and reproducibility) of the refined manualized intervention. The qualitative and quantitative assessment during this RCT will allow for the evaluation of successful replication of the intervention and the circumstances that may contribute to (or hinder) its success. The ultimate product at completion of this project will be a manualized CRISP intervention that is proven to be as effective as the original intervention and available for broader use and further evaluation.

Quick answers

Who received award 90IFDV0051?

90IFDV0051 was awarded to Kessler Foundation, Inc. by National Institute on Disability Independent Living and Rehabilitation Research (Administration for Community Living) on September 23, 2026.

How much is award 90IFDV0051 worth?

$249,426 has been obligated on 90IFDV0051.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award